Attorneys Ask that Purdue Seek Political Contribution Permission
OxyContin manufacturer should be required to ask for judge’s permission before making political contributions, creditors contend.
Sara is a credited writer, editor, contributor, and essayist, as well as a novelist and poet with more than two decades of experience in media arts. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara is a member of the International Association of Writers & Editors, has received numerous awards and has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She is also a mental health therapist, clinical supervisor and entrepreneur, holding an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling (graduating with a 4.2/4.0 GPA). Additionally, she is a member of Chi Sigma Iota, was on her local chapter's board, and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her nine books can be found on Amazon.
OxyContin manufacturer should be required to ask for judge’s permission before making political contributions, creditors contend.
Brokers face charges in insurance fraud schemes.
Vermonters will need to keep their food scraps out of the trash with the passage of a new composting law.
Virginia is facing an unprecedented crisis as the coronavirus compounds its opioid issue.
The coronavirus is limiting access to treatment options addicts desperately need.
Pharmacies want physicians to be held accountable for prescribing addictive opioids.
A new NEJM study suggests supervised injection is a valid addiction treatment option.
Housing units help the homeless have a place to call home.
FSU forced to follow up with telecommute note after the university receives backlash from employees.
Drug development company is determined, despite second rejection, to get pain management drug approved.